22-23 July 2016 - Phoenicia Intercontinental Beirut CME CREDITS

22-23 July 2016 - Phoenicia Intercontinental Beirut CME CREDITS

"This is a personal invitation. We would like to remind you that according to the MEA code of pharmaceutical promotional practices,
inclusion of a health care professional's spouse or other guest to any promotional, professional or scientific event is not appropriate.”
SALEV.ONC.16.07.0151
Sanofi Aventis Liban SAL - Corniche El Nahr, Pierre Gemayel street, Holcom building, 2nd floor.
Beirut, Lebanon. P.O Box: 110697, Phone: +961 1 440 220, Fax: +961 1 562 264
CME
CREDITS
22-23 July 2016 - Phoenicia Intercontinental Beirut
Sanofi
2 Middle East Solid Tumors Meeting
nd
22-23 July 2016- Phoenicia Intercontinental Beirut
New Horizons for the Management of Metastatic Castration
Resistant Prostate Cancer : Optimizing Treatment Outcomes
09:00-09:10
Welcome Note & Opening - Raghid Khoury MD, Urology - President of Lebanese Urology Society
09:10 – 10:10
Plenary I: The Heterogeneity of Prostate Cancer
Panelists: Joseph Makdessi MD, Oncology LB
Abdullah Al Sharm MD, Oncology KSA
Fouad Abotaleb MD, Oncology Egypt
09:10 – 09:30
Understanding the Heterogeneity of Prostate Cancer - Christopher Sweeney, MD
09:30 – 09:50
Personalized Medicine in Prostate Cancer - Marwan Ghosn MD, Oncology LB
09:50 – 10:10
Discussion ( Panelists & Speakers )
10:10 – 10:25
Coffee Break
10:25 – 11:25
Plenary II: Emerging Biomarkers in Prostate Cancer
Panelists: Nabil Chamseddine MD, Oncology LB
Muhammad Azfar MD, Oncology KSA
Mohamad Abdelkader MD, Oncology Egypt
Sanofi
2 Middle East Solid Tumors Meeting
nd
22-23 July 2016- Phoenicia Intercontinental Beirut
11:10 – 11:25
11:25 -12:25
Discussion ( Panelists & Speakers )
Plenary III: Advanced Prostate Cancer: Guidelines and New Paradigms
Panelists: Mervat Mahrous MD, Oncology KSA
Mohamad Bulbul MD, Urology LB
Hesham El Ghazaly MD, Oncology Egypt
Sanofi
2 Middle East Solid Tumors Meeting
nd
22-23 July 2016- Phoenicia Intercontinental Beirut
14:30 – 15:30
Plenary V: Clinical Cases Presentation and Discussion ( Voting Session )
Panelists : Georges Kassaf MD , Urology LB
Abdullah El Sharm MD, Oncology KSA
Ramy Ghaly MD, Oncology Egypt
14:30 – 14:40
Case 1 : Pierre Sarkis MD, Urology LB
14:40 – 14:50
Case 2 : Ali Jubran MD, Oncology KSA
14:50 – 15:00
Case 3 : Salem Eid, MD Oncology Egypt
11:25 – 11:45
The Role of Modern Imaging in Monitoring Patients With Advanced Prostate Cancer
Elie Nemr MD , Urology LB
11:45 – 12:15
Paradigm Change in Prostate Cancer Management Protocols - Christopher Sweeney, MD
15:00 – 15:30
Discussion ( Panelists & Speakers )
12:15 – 12:25
Discussion ( Panelists & Speakers )
15:30 – 15:45
Coffee Break
12:25- 13:30
Plenary IV: Sequencing Therapies in mCRPC
Chairman : Georges Chahine MD, Oncology LB
Panelists : Mohamad Abdullah MD, Oncology Egypt
Amin Al Tigani MD, Oncology KSA
15:45 – 17:00
Plenary VI: MDT Approach : Experience Sharing
Panelists : Raghid Khoury MD, Urology LB
Ziad Salem MD, Oncology LB
Mohamad Moussa MD, Urology LB
12:25 – 13:00
Best Sequencing of Current Therapies in mCRPC - Christopher Sweeney, MD
15:45 – 16:00
13:00 – 13:10
Quality of Life in Advanced Prostate Cancer - Georges Chahine MD, Oncology LB
Evaluation of Multidisciplinary Team Meeting in Uro-Oncology:
Notre Dame des Secours University Hospital Experience
Raghid Khoury MD, Urology LB
16:00 – 16:15
Case 1 : Khaled Ibrahim MD, Oncology LB
Case 2 : Khaled Sayed MD, Urology LB
10:25 – 10:40
The Prognostic Role of Neutrophil Lymphocyte Ratio in Prostate Cancer - Joseph Kattan MD, Oncology LB
10:40 – 10:55
Biomarkers Development in Prostate Cancer - Jawaher Ansari MD , Oncology KSA
13:10 – 13:30
Discussion ( Panelists & Speakers )
16:15 – 16:30
10:55 – 11:10
Challenges in Our Practice - Fadi Farhat MD , Oncology LB
13:30 – 14:30
Lunch
16:30 – 17:00 Discussion ( Panelists & Speakers)